Evaluation of pre-analytical, demographic, behavioural and metabolic variables on fibrinolysis and haemostasis activation markers utilised to assess hypercoagulability.
Author(s): Stegnar M, Cuderman TV, Bozic M
Publication: Clin Chem Lab Med, 2007, Vol. 45, Page 40-6
PubMed ID: 17243913 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine the correlation of age, gender, smoking status, body mass index (BMI), blood pressure, cholesterol, and triglyceride levels with fibrinolytic variables (t-PA activity and antigen, plasminogen activator inhibitor-1 (PAI-1) activity and antigen, and euglobulin clot lysis time) and haemostasis activation markers (prothrombin fragment 1 + 2 (F1 + 2), thrombin-antithrombin (TAT) complex, and D-dimer) in healthy individuals. Comparisons were also made between blood specimens collected by a trained and untrained nurse.
Summary of Findings:
t-PA antigen was significantly higher in men than women, but there was no effect of smoking status. None of the other fibrinolytic variables or haemostasis activation markers were affected by gender or smoking. However several independent correlations were observed between the fibrinolytic variables and preanalytical metabolic variables. Most significantly, t-PA antigen, PAI activity, and PAI-1 antigen were each associated with BMI and triglyceride levels. t-PA antigen was further influenced by low-density lipoprotein-cholesterol (LDL-C) levels and t-PA activity was significantly associated with high-density lipoprotein-cholesterol (HDL-C) levels. The haemostasis activation markers also showed some significant correlations with preanalytical metabolic and demographic variables. Importantly TAT complex and D-dimer were negatively and positively associated with age, respectively. D-dimer was also significantly influenced by total cholesterol and LDL-C levels, while F1 + 2 was negatively associated with HDL-C levels. Blood specimens collected by a nurse who was untrained in phlebotomy technique showed significantly higher values for all haemostasis activation markers when compared to specimens obtained from the same donors by a trained nurse.
Biospecimens
Preservative Types
- Frozen
Diagnoses:
- Normal
Platform:
Analyte Technology Platform Protein ELISA Morphology Macroscopic observation Peptide ELISA Steroid Colorimetric assay Lipid Colorimetric assay Lipoprotein Colorimetric assay Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Biospecimen Acquisition Method of fluid acquisition Staff trained/experienced in phlebotomy
Staff untrained/inexperienced in phlebotomy
Preaquisition Patient age 20-92 y
Preaquisition Patient gender Female
Male
Preaquisition Other drugs Smoker
Non-smoker
Preaquisition Blood pressure Various values
Preaquisition Biomarker level Total cholesterol
HDL-C
LDL-C
Triglycerides
Biospecimen Aliquots and Components Blood and blood products Serum
Platelet-poor plasma
